Due: May 20, 2026
CPE CBRND is conducting essential market research for the Advanced Differential Diagnostics (ADD) program, an existing Program of Record that is developing new diagnostic capabilities in a phased approach. This program is dedicated to identifying and advancing mature diagnostics that utilize the warfighter’s early response to the pathogen. CPE CBRND will be focused on developing and delivering diagnostics that help meet operational and mission needs across the conflict continuum. The goal is to create a resilient force, capable of withstanding, mitigating, and recovering from the complex injuries caused by CBRN threats.
We are seeking information from industry partners developing innovative solutions that diagnose infection based on measures of the body’s response, rather than targeting specific pathogens. These tests will rely on host biomarkers to make diagnostic determinations; for example, peripheral blood cellular gene expression patterns, rather than direct detection of a pathogen.e capability gap.
Responding to this opportunity requires membership in the Medical CBRN Defense Consortium (MCDC). This Consortium releases numerous solicitations throughout the year, so even if this opportunity may not end up being right for you, we strongly encourage you to join, so you are ready for the next opportunity.
Complete the form below and a program representative will reach out to you shortly to support you through the process.